Similar articles

• Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects.

  Krishnaswamy K, Kalamegham R, Naidu NA. Krishnaswamy K, et al. Br J Clin Pharmacol. 1984 Feb;17(2):139-46. doi: 10.1111/j.1365-2125.1984.tb02328.x. Br J Clin Pharmacol. 1984. PMID: 6704283 Free PMC article.
• Effect of famotidine on oxidative drug metabolism.

  Somerville KW, Kitchingman GA, Langman MJ. Somerville KW, et al. Eur J Clin Pharmacol. 1986;30(3):279-81. doi: 10.1007/BF00541528. Eur J Clin Pharmacol. 1986. PMID: 2874031
• Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

  Vesell ES, Passananti GT, Glenwright PA, Dvorchik BH. Vesell ES, et al. Clin Pharmacol Ther. 1975 Sep;18(3):259-72. doi: 10.1002/cpt1975183259. Clin Pharmacol Ther. 1975. PMID: 1164816
• Drug metabolism in thyroid disease.

  Eichelbaum M. Eichelbaum M. Clin Pharmacokinet. 1976;1(5):339-50. doi: 10.2165/00003088-197601050-00002. Clin Pharmacokinet. 1976. PMID: 797503 Review.
• Regulation of drug metabolism in man by environmental factors.

  Alvares AP, Pantuck EJ, Anderson KE, Kappas A, Conney AH. Alvares AP, et al. Drug Metab Rev. 1979;9(2):185-205. doi: 10.3109/03602537908993890. Drug Metab Rev. 1979. PMID: 385270 Review. No abstract available.